Molander, Pauliina <br/><br/>
Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.  [electronic resource] 

 -  Journal of Crohn's & colitis  Oct 2013 
 - 730-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1016/j.crohns.2012.10.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>C-Reactive Protein--metabolism<br/>Child<br/>Child, Preschool<br/>Colitis, Ulcerative--drug therapy<br/>Colonoscopy<br/>Crohn Disease--drug therapy<br/>Disease-Free Survival<br/>Drug Therapy, Combination<br/>Feces--chemistry<br/>Female<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Infliximab<br/>Leukocyte L1 Antigen Complex--analysis<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult